ArticleTransplantation direct2025
Barriers Limiting Equity in Access to Pretransplant Evaluation Among Predialysis Patients: A Cohort Study.
Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney transplantation is the optimal treatment for end-stage renal disease; however, referral for pretransplant evaluation remains inconsistent. We aimed to compare patients deemed eligible for pretransplant evaluation with those whose eligibility status was undetermined. Methods: We conducted a single-center retrospective cohort study of patients aged ≤80 y, followed-up in a chronic kidney disease (CKD) clinic as of June 2021. We compared demographic, clinical characteristics, and survival prognosis scores between these groups. Results: Of the 572 patients followed in the clinic, 395 were aged ≤80 y. Among them, 203 had progressive disease, defined as CKD stage V or CKD stage IV with an estimated glomerular filtration rate (eGFR) projected to fall below 15 mL/min/1.73 m Conclusions: A substantial proportion of patients theoretically eligible for pretransplant evaluation had an undetermined referral status. Our findings suggest that several of these patients share similar age, comorbidity profiles, and survival prospects with those already deemed eligible for pretransplant evaluation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.